journal article·2021-10Open access

PAMAM and polyester dendrimers as favipiravir nanocarriers: a comparative study using DFT method

Sekineh Bazyari-Delavar, Farideh Badalkhani-Khamseh, Azadeh Ebrahim-Habibi, Nasser L. Hadipour

Journal of Nanoparticle Research· Volume 23· Issue 10

Abstract

The electronic sensitivity and reactivity of polyamidoamine (PAMAM) and polyester dendrimers toward favipiravir (T705) were inspected using density functional theory method. The T705 drug is adsorbed on the surface of PAMAM and polyester dendrimers with the binding energy of -27.26 and -26.80 kcal mol-1, respectively, in the solvent phase. The energy gap of PAMAM and polyester dendrimers reduced by about 32% and 27%, indicating that the electrical conductance of carriers become 8.16 × 1023 and 4.41 × 1022 times higher, upon T705 adsorption. The work function (Φ) value of PAMAM and polyester is changed about 1.53 and 0.71 eV, respectively. Thus, PAMAM dendrimer is about 2.5 times stronger Φ-type sensor than polyester dendrimer. The recovery time for T705 desorption from the PAMAM and polyester surface is predicted to be 9.2 × 103 and 4.2 × 103 s, respectively, at physiological environment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Tomalia DA (2004) Aldrichimica Acta 37:39
2. A.P. Dias, S. da Silva Santos, J.V. da Silva, R. Parise Filho, E.I. Ferreira, O. El Seoud, J. Giarolla, International journal of pharmaceutics (2019) 118814.10.1016/j.ijpharm.2019.118814 ↗
3. Badalkhani-Khamseh F, Ebrahim-Habibi A, Hadipour NL (2019) J Mol Recognit 32:e275710.1002/jmr.2757 ↗
4. Kesharwani P, Jain K, Jain NK (2014) Prog Polym Sci 39:26810.1016/j.progpolymsci.2013.07.005 ↗
5. A. Chauhan, B. Anton, M.K. Singh, Pharmaceutical applications of dendrimers, Elsevier, 2020, p. 59.10.1016/B978-0-12-814527-2.00003-2 ↗
6. Badalkhani-Khamseh F, Ebrahim-Habibi A, Hadipour NL (2017a) J Comput Aided Mol Des 31:109710.1007/s10822-017-0091-9 ↗
7. K. Yamamoto, T. Imaoka, M. Tanabe, T. Kambe, Chemical reviews (2019).
8. Esfand R, Tomalia DA (2001) Drug Discovery Today 6:42710.1016/S1359-6446(01)01757-3 ↗
9. Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, Valliant JF, Adronov A (2009) J Am Chem Soc 131:290610.1021/ja8078175 ↗
10. Lim J, Simanek EE (2012) Adv Drug Deliv Rev 64:82610.1016/j.addr.2012.03.008 ↗
11. Feliu N, Walter MV, Montañez MI, Kunzmann A, Hult A, Nyström A, Malkoch M, Fadeel B (2012) Biomaterials 33:197010.1016/j.biomaterials.2011.11.054 ↗
12. E. Pedziwiatr-Werbicka, K. Milowska, V. Dzmitruk, M. Ionov, D. Shcharbin, M. Bryszewska, European Polymer Journal (2019).
13. Parashar AK, Patel P, Gupta AK, Jain NK, Kurmi BD (2019) Drug Deliv Lett 9:24810.2174/2210303109666190401231920 ↗
14. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) Polym J 17:11710.1295/polymj.17.117 ↗
15. S. Akhtar, B. Chandrasekhar, M.H. Yousif, W. Renno, I.F. Benter, A.Z. El-Hashim, Nanomedicine: nanotechnology, biology and medicine 18 (2019) 78.10.1016/j.nano.2019.02.012 ↗
16. Holmes AM, Heylings JR, Wan K-W, Moss GP (2019) Int J Antimicrob Agents 53:50010.1016/j.ijantimicag.2018.12.012 ↗
17. S. Kheiriabad, M. Ghaffari, J.E.N. Dolatabadi, M.R. Hamblin, RNA interference and CRISPR technologies, Springer, 2020, p. 91.10.1007/978-1-0716-0290-4_5 ↗
18. Badalkhani-Khamseh F, Bahrami A, Ebrahim-Habibi A, Hadipour NL (2017b) Chem Phys Lett 684:10310.1016/j.cplett.2017.06.042 ↗
19. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) Biomaterials 24:112110.1016/S0142-9612(02)00445-3 ↗
20. S. Hong, P.R. Leroueil, E.K. Janus, J.L. Peters, M.-M. Kober, M.T. Islam, B.G. Orr, J.R. Baker Jr, M.M. Banaszak Holl, Bioconjugate chemistry 17 (2006) 728.10.1021/bc060077y ↗
21. Winnicka K, Bielawski K, Rusak M, Bielawska A (2009) J Health Sci 55:16910.1248/jhs.55.169 ↗
22. Cakara D, Kleimann J, Borkovec M (2003) Macromolecules 36:420110.1021/ma0300241 ↗
23. Mukherjee SP, Lyng FM, Garcia A, Davoren M, Byrne HJ (2010a) Toxicol Appl Pharmacol 248:25910.1016/j.taap.2010.08.016 ↗
24. Mukherjee SP, Davoren M, Byrne HJ (2010b) Toxicol in Vitro 24:16910.1016/j.tiv.2009.09.014 ↗
25. Jain K, Kesharwani P, Gupta U, Jain N (2010) Int J Pharm 394:12210.1016/j.ijpharm.2010.04.027 ↗
26. Svenson S (2009) Eur J Pharm Biopharm 71:44510.1016/j.ejpb.2008.09.023 ↗
27. Shi X, Lesniak W, Islam MT, MuÑiz MC, Balogh LP, Baker JR Jr (2006) Colloids Surf, A 272:13910.1016/j.colsurfa.2005.07.031 ↗
28. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H (2007) Bioconjug Chem 18:205410.1021/bc0603889 ↗
29. Ihre H, Hult A, Söderlind E (1996) J Am Chem Soc 118:638810.1021/ja954171t ↗
30. Ihre HR, Padilla De Jesús OL, Szoka FC, Fréchet JM (2002) Bioconjug Chem 13:44310.1021/bc010102u ↗
31. P. Stenström, KTH Royal Institute of Technology, 2020.
32. K. Shiraki, T. Daikoku, Pharmacology & therapeutics (2020) 107512.10.1016/j.pharmthera.2020.107512 ↗
33. Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K (2005) Antimicrob Agents Chemother 49:98110.1128/AAC.49.3.981-986.2005 ↗
34. Bai CQ, Mu JS, Kargbo D, Song YB, Niu WK, Nie WM, Kanu A, Liu WW, Wang YP, Dafae F (2016) Clin Infect Dis 63:128810.1093/cid/ciw571 ↗
35. Oestereich L, Rieger T, Lüdtke A, Ruibal P, Wurr S, Pallasch E, Bockholt S, Krasemann S, Muñoz-Fontela C, Günther S (2016) J Infect Dis 213:93410.1093/infdis/jiv522 ↗
36. H. Tani, A. Fukuma, S. Fukushi, S. Taniguchi, T. Yoshikawa, N. Iwata-Yoshikawa, Y. Sato, T. Suzuki, N. Nagata, H. Hasegawa, mSphere 1 (2016) e00061.10.1128/mSphere.00061-15 ↗
37. Dong L, Hu S, Gao J (2020) Drug Discoveries & Therapeutics 14:5810.5582/ddt.2020.01012 ↗
38. G. Li, E. De Clercq, Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Publishing Group, 2020.10.1038/d41573-020-00016-0 ↗
39. Bazyari-Delavar S, Badalkhani-Khamseh F, Ebrahim-Habibi A, Hadipour NL (2020) Comput Theor Chem 1189:11298310.1016/j.comptc.2020.112983 ↗
40. Karimzadeh S, Safaei B, Jen T-C (2021) J Mol Liq 322:11489010.1016/j.molliq.2020.114890 ↗
41. L. Piela, Ideas of quantum chemistry, Elsevier, 2013.
42. Karimzadeh S, Safaei B, Jen T-C (2020) J Mol Graph Model 101:10774510.1016/j.jmgm.2020.107745 ↗
43. Zhao Y, Truhlar DG (2008) Theoret Chem Acc 120:21510.1007/s00214-007-0310-x ↗
44. Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, Koseki S, Matsunaga N, Nguyen KA, Su S (1993) J Comput Chem 14:134710.1002/jcc.540141112 ↗
45. Grimme S (2011) Wiley Interdisciplinary Reviews: Computational Molecular Science 1:211
46. Jain MMS, Barhate SD (2021) Asian Journal of Pharmaceutical Research 11:3910.5958/2231-5691.2021.00008.3 ↗
47. Reed AE, Curtiss LA, Weinhold F (1988) Chem Rev 88:89910.1021/cr00088a005 ↗
48. H. Zhong, R. Quhe, Y. Wang, Z. Ni, M. Ye, Z. Song, Y. Pan, J. Yang, L. Yang, M. Lei, Scientific reports 6 (2016) 1.10.1038/srep21786 ↗
49. C.C. Marston, G.G. Balint‐Kurti, The Journal of chemical physics 91 (1989) 357110.1063/1.456888 ↗
50. N.M. O'boyle, A.L. Tenderholt, K.M. Langner, Journal of computational chemistry 29 (2008) 839.10.1002/jcc.20823 ↗
51. Fallon L (1973) Acta Crystallographica Section B: Structural Crystallography and Crystal. Chemistry 29:2549
52. Hazrati MK, Bagheri Z, Bodaghi A (2017) Physica E 89:7210.1016/j.physe.2017.02.009 ↗
53. Hosseinian A, Vessally E, Bekhradnia A, Nejati K, Rahimpour G (2017) Thin Solid Films 640:9310.1016/j.tsf.2017.08.049 ↗
54. R.G. Parr, L.v. Szentpály, S. Liu, Journal of the American Chemical Society 121 (1999) 1922.10.1021/ja983494x ↗